PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews

Matthew J. Page; David Moher; Patrick M. Bossuyt; Isabelle Boutron; Tammy C. Hoffmann; Cynthia D. Mulrow; Larissa Shamseer; Jennifer M. Tetzlaff; Elie A. Akl; Sue E. Brennan; Roger Chou; Julie Glanville; Jeremy M. Grimshaw; Asbjørn Hróbjartsson; Manoj M. Lalu; Tianjing Li; Elizabeth W. Loder; Evan Mayo-Wilson; Steve Mcdonald; Luke A. Mcguinness; Lesley A. Stewart; James Thomas; Andrea C. Tricco; Vivian A. Welch; Penny Whiting; Joanne E. Mckenzie

doi:10.1136/bmj.n160

PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews

Matthew J. Page, David Moher, Patrick M. Bossuyt, Isabelle Boutron, Tammy C. Hoffmann, Cynthia D. Mulrow, Larissa Shamseer, Jennifer M. Tetzlaff, Elie A. Akl, Sue E. Brennan, Roger Chou, Julie Glanville, Jeremy M. Grimshaw, Asbjørn Hróbjartsson, Manoj M. Lalu, Tianjing Li, Elizabeth W. Loder, Evan Mayo-Wilson, Steve Mcdonald, Luke A. McguinnessLesley A. Stewart, James Thomas, Andrea C. Tricco, Vivian A. Welch, Penny Whiting, Joanne E. Mckenzie

Medical Informatics and Clinical Epidemiology

Research output: Contribution to journal › Review article › peer-review

3816 Scopus citations

Abstract

The methods and results of systematic reviews should be reported in sufficient detail to allow users to assess the trustworthiness and applicability of the review findings. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement was developed to facilitate transparent and complete reporting of systematic reviews and has been updated (to PRISMA 2020) to reflect recent advances in systematic review methodology and terminology. Here, we present the explanation and elaboration paper for PRISMA 2020, where we explain why reporting of each item is recommended, present bullet points that detail the reporting recommendations, and present examples from published reviews. We hope that changes to the content and structure of PRISMA 2020 will facilitate uptake of the guideline and lead to more transparent, complete, and accurate reporting of systematic reviews.

Original language	English (US)
Article number	n160
Journal	The BMJ
Volume	372
DOIs	https://doi.org/10.1136/bmj.n160
State	Published - Mar 29 2021

ASJC Scopus subject areas

General Medicine

Access to Document

10.1136/bmj.n160

Cite this

Page, M. J., Moher, D., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., Mcdonald, S., ... Mckenzie, J. E. (2021). PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews. The BMJ, 372, Article n160. https://doi.org/10.1136/bmj.n160

Page, MJ, Moher, D, Bossuyt, PM, Boutron, I, Hoffmann, TC, Mulrow, CD, Shamseer, L, Tetzlaff, JM, Akl, EA, Brennan, SE, Chou, R, Glanville, J, Grimshaw, JM, Hróbjartsson, A, Lalu, MM, Li, T, Loder, EW, Mayo-Wilson, E, Mcdonald, S, Mcguinness, LA, Stewart, LA, Thomas, J, Tricco, AC, Welch, VA, Whiting, P & Mckenzie, JE 2021, 'PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews', The BMJ, vol. 372, n160. https://doi.org/10.1136/bmj.n160

@article{4870954761d74625ab4f8a9557094bd5,

title = "PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews",

abstract = "The methods and results of systematic reviews should be reported in sufficient detail to allow users to assess the trustworthiness and applicability of the review findings. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement was developed to facilitate transparent and complete reporting of systematic reviews and has been updated (to PRISMA 2020) to reflect recent advances in systematic review methodology and terminology. Here, we present the explanation and elaboration paper for PRISMA 2020, where we explain why reporting of each item is recommended, present bullet points that detail the reporting recommendations, and present examples from published reviews. We hope that changes to the content and structure of PRISMA 2020 will facilitate uptake of the guideline and lead to more transparent, complete, and accurate reporting of systematic reviews.",

author = "Page, {Matthew J.} and David Moher and Bossuyt, {Patrick M.} and Isabelle Boutron and Hoffmann, {Tammy C.} and Mulrow, {Cynthia D.} and Larissa Shamseer and Tetzlaff, {Jennifer M.} and Akl, {Elie A.} and Brennan, {Sue E.} and Roger Chou and Julie Glanville and Grimshaw, {Jeremy M.} and Asbj{\o}rn Hr{\'o}bjartsson and Lalu, {Manoj M.} and Tianjing Li and Loder, {Elizabeth W.} and Evan Mayo-Wilson and Steve Mcdonald and Mcguinness, {Luke A.} and Stewart, {Lesley A.} and James Thomas and Tricco, {Andrea C.} and Welch, {Vivian A.} and Penny Whiting and Mckenzie, {Joanne E.}",

note = "Publisher Copyright: {\textcopyright} 2019 Author(s) (or their employer(s)).",

year = "2021",

month = mar,

day = "29",

doi = "10.1136/bmj.n160",

language = "English (US)",

volume = "372",

journal = "The BMJ",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - PRISMA 2020 explanation and elaboration

T2 - Updated guidance and exemplars for reporting systematic reviews

AU - Page, Matthew J.

AU - Moher, David

AU - Bossuyt, Patrick M.

AU - Boutron, Isabelle

AU - Hoffmann, Tammy C.

AU - Mulrow, Cynthia D.

AU - Shamseer, Larissa

AU - Tetzlaff, Jennifer M.

AU - Akl, Elie A.

AU - Brennan, Sue E.

AU - Chou, Roger

AU - Glanville, Julie

AU - Grimshaw, Jeremy M.

AU - Hróbjartsson, Asbjørn

AU - Lalu, Manoj M.

AU - Li, Tianjing

AU - Loder, Elizabeth W.

AU - Mayo-Wilson, Evan

AU - Mcdonald, Steve

AU - Mcguinness, Luke A.

AU - Stewart, Lesley A.

AU - Thomas, James

AU - Tricco, Andrea C.

AU - Welch, Vivian A.

AU - Whiting, Penny

AU - Mckenzie, Joanne E.

PY - 2021/3/29

Y1 - 2021/3/29

N2 - The methods and results of systematic reviews should be reported in sufficient detail to allow users to assess the trustworthiness and applicability of the review findings. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement was developed to facilitate transparent and complete reporting of systematic reviews and has been updated (to PRISMA 2020) to reflect recent advances in systematic review methodology and terminology. Here, we present the explanation and elaboration paper for PRISMA 2020, where we explain why reporting of each item is recommended, present bullet points that detail the reporting recommendations, and present examples from published reviews. We hope that changes to the content and structure of PRISMA 2020 will facilitate uptake of the guideline and lead to more transparent, complete, and accurate reporting of systematic reviews.

AB - The methods and results of systematic reviews should be reported in sufficient detail to allow users to assess the trustworthiness and applicability of the review findings. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement was developed to facilitate transparent and complete reporting of systematic reviews and has been updated (to PRISMA 2020) to reflect recent advances in systematic review methodology and terminology. Here, we present the explanation and elaboration paper for PRISMA 2020, where we explain why reporting of each item is recommended, present bullet points that detail the reporting recommendations, and present examples from published reviews. We hope that changes to the content and structure of PRISMA 2020 will facilitate uptake of the guideline and lead to more transparent, complete, and accurate reporting of systematic reviews.

UR - http://www.scopus.com/inward/record.url?scp=85103235741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103235741&partnerID=8YFLogxK

U2 - 10.1136/bmj.n160

DO - 10.1136/bmj.n160

M3 - Review article

C2 - 33781993

AN - SCOPUS:85103235741

SN - 0959-8146

VL - 372

JO - The BMJ

JF - The BMJ

M1 - n160

ER -

PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this